Regional Analysis
Global DNA/Gene Microarray Market- Regional Analysis
- Among regions, North America is estimated to hold a dominant position in the global DNA/gene microarray market over the forecast period. North America is estimated to hold 33.5% of the market share in 2023. The global DNA/gene microarray market is expected to witness significant growth in the coming years, owing to increasing product launches by key market players. For instance, in March 2020, Agilent Technologies Inc. announced the launch of Agilent GenetiSure Cyto microarrays for prenatal and postnatal research. The new Agilent GenetiSure Cyto microarrays include updated, clinically relevant content from respected databases. The probes on the Cyto microarrays provide high-resolution detection of copy number variations and copy-neutral loss of heterozygosity associated with developmental delay, neuropsychiatric disorders, intellectual disability, congenital anomalies, or unexplained dysmorphic features in constitutional DNA samples.
Based on region, the market is segmented into North America, Latin America. Europe, Asia Pacific, Middle East and Africa. Out of which, the North America region is expected to dominate the market over the forecast period, and this is due to the increasing product approval from the U.S FDA (Food and Drug Administration) by the market players in this region.
- Among all the segmentations, the type segment has the highest potential due to the increasing inorganic growth strategies, such as acquisitions and others, by the key market players. For instance, in September 2021, SCHOTT MINIFAB, a subsidiary of SCHOTT, a technology company that develops and manufactures microfluidic devices for point-of-care and life sciences consumables, announced that they had acquired Applied Microarrays Inc. (AMI), a U.S.-based company, which will further help the company strengthens its single-source contract manufacturing solution in the North America Region.
U.S.: 
U.K. : 
India : 